| Title | Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas |
| Authors | Ma, Jun Song, Yuqin Xie, Yan Zhang, Hui-Lai Shuang, Yuerong Peng, Zhigang Fei, Li Huang, Yunhong Zhao, Weili Huang, Wenrong Pan, Yali Liu, Mingying Ran, Feiwu Feng, Hui Yao, Sheng Keegan, Patricia Zou, Jianjun Zhu, Jun |
| Affiliation | Harbin Inst Hematol & Oncol, Harbin, Peoples R China Peking Univ, Canc Hosp & Inst, Beijing, Peoples R China Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China Guangxi Med Univ, Affiliated Hosp 1, Naning, Peoples R China Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China Guizhou Med Univ, Affiliated Canc Hosp, Guiyang, Peoples R China Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China Chinese Peoples Liberat Army, Med Ctr 5, Gen Hosp, Beijing, Peoples R China Shanghai Junshi Biosci, Shanghai, Peoples R China Top Alliance Biosci, Rockville, MD USA Peking Univ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing, Peoples R China |
| Issue Date | 15-Nov-2022 |
| Publisher | BLOOD |
| URI | http://hdl.handle.net/20.500.11897/670848 |
| ISSN | 0006-4971 |
| DOI | 10.1182/blood-2022-157497 |
| Indexed | CPCI-S(ISTP) SCI(E) |
| Appears in Collections: | 北京肿瘤医院 |
